Chapel Hill, NC, United States of America

Bruce A Sullenger

This inventor holds 41 USPTO granted patents and 22 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Aptamer Technologies. Top assignees: Duke University, The Ohio State University. Active years: 2007-2026.

USPTO Granted Patents = 41 (Patent Applications = 22)

% Patents Active = 82.9

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 155(Granted Patents)

Location History:

Chapel Hill, NC (US) (2013)
Durham, NC (US) (2007 - 2024)

Company Filing History:

The Ohio State University

patents

where one patent can have more than one assignee

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Aptamers

Coagulation Control

Cancer Treatment

Polycationic Polymers

Splice-Switching Oligonucleotides

Thrombus Imaging

Electrospun Nanofibers

Nucleolin-Targeting

Immunostimulators

Platelet Inhibition

RNA Identification

Pharmacological Modulators

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12697401 - THROMBUS IMAGING APTAMERS AND METHODS OF USING SAME (2026-08-04),

2. 12577568 - METHODS FOR CONTROLLING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) COAGULATION (2026-03-17),

3. 12514872 - Polycationic polymers for use in treating and detecting cancer (2026-01-06),

4. 12447464 - Polycationic microfibers and methods of using the same (2025-10-21),

5. 12398425 - Antidote-mediated reversal of extracellular aptamer staining (2025-08-26),

6. 12312588 - Nucleolin-targeting aptamers and methods of using the same (2025-05-27),

7. 12071626 - Splice-switching oligonucleotides and methods of use (2024-08-27),

8. 11965160 - Von Willebrand Factor (VWF)-targeting agents and methods of using the same (2024-04-23),

9. 11866689 - Splice-switching oligonucleotides and methods of use (2024-01-09),

10. 11713464 - Nucleolin-targeting aptamers and methods of using the same (2023-08-01),

11. 11634772 - Antidote-mediated reversal of extracellular aptamer staining (2023-04-25),

12. 11617779 - Inhibition of endosomal toll-like receptor activation (2023-04-04),

13. 11613756 - Compositions and methods for differential induction of cell death and interferon expression (2023-03-28),

14. 11565002 - Thrombus imaging aptamers and methods of using same (2023-01-31),

15. 11512290 - Compositions and methods for cellular reprogramming (2022-11-29),

Title: Bruce A Sullenger - Pioneering Inventor from Chapel Hill, NC

Introduction: Bruce A Sullenger is a renowned inventor hailing from Chapel Hill, North Carolina. With a passion for innovation and a drive to make a difference, he has made significant contributions to the field of patents and inventions.

Latest Patents: Bruce A Sullenger holds several patents in the areas of biotechnology and medical devices, showcasing his expertise in cutting-edge technologies that aim to improve healthcare outcomes.

Career Highlights: Throughout his career, Bruce A Sullenger has been instrumental in developing groundbreaking inventions that have revolutionized the medical industry. His innovative solutions have garnered recognition and praise from peers and professionals alike.

Collaborations: Bruce A Sullenger has collaborated with leading research institutions and universities to further his inventions and bring them to market. His partnerships have been crucial in advancing his ideas and turning them into tangible products that benefit society.

Conclusion: Bruce A Sullenger's dedication to innovation and his commitment to improving the world through his inventions make him a standout figure in the field of patents. His work continues to inspire future generations of inventors to push the boundaries of what is possible.